Logo image of BLKB

BLACKBAUD INC (BLKB) Stock Fundamental Analysis

USA - NASDAQ:BLKB - US09227Q1004 - Common Stock

64.36 USD
+1.32 (+2.09%)
Last: 10/20/2025, 4:20:00 PM
64.36 USD
0 (0%)
After Hours: 10/20/2025, 4:20:00 PM
Fundamental Rating

3

Taking everything into account, BLKB scores 3 out of 10 in our fundamental rating. BLKB was compared to 285 industry peers in the Software industry. While BLKB is still in line with the averages on profitability rating, there are concerns on its financial health. BLKB has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BLKB was profitable.
In the past year BLKB had a positive cash flow from operations.
In multiple years BLKB reported negative net income over the last 5 years.
Each year in the past 5 years BLKB had a positive operating cash flow.
BLKB Yearly Net Income VS EBIT VS OCF VS FCFBLKB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

With a Return On Assets value of -10.63%, BLKB is not doing good in the industry: 62.11% of the companies in the same industry are doing better.
BLKB's Return On Equity of -317.65% is on the low side compared to the rest of the industry. BLKB is outperformed by 83.16% of its industry peers.
With an excellent Return On Invested Capital value of 10.06%, BLKB belongs to the best of the industry, outperforming 85.96% of the companies in the same industry.
Industry RankSector Rank
ROA -10.63%
ROE -317.65%
ROIC 10.06%
ROA(3y)-4.27%
ROA(5y)-2.45%
ROE(3y)-68.43%
ROE(5y)-40.54%
ROIC(3y)N/A
ROIC(5y)N/A
BLKB Yearly ROA, ROE, ROICBLKB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

BLKB's Operating Margin of 13.95% is fine compared to the rest of the industry. BLKB outperforms 80.00% of its industry peers.
BLKB's Operating Margin has improved in the last couple of years.
The Gross Margin of BLKB (56.72%) is worse than 63.51% of its industry peers.
BLKB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.95%
PM (TTM) N/A
GM 56.72%
OM growth 3Y55.49%
OM growth 5Y26.14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.94%
GM growth 5Y0.66%
BLKB Yearly Profit, Operating, Gross MarginsBLKB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BLKB is destroying value.
The number of shares outstanding for BLKB has been reduced compared to 1 year ago.
BLKB has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BLKB has a worse debt to assets ratio.
BLKB Yearly Shares OutstandingBLKB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BLKB Yearly Total Debt VS Total AssetsBLKB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

BLKB has an Altman-Z score of 1.22. This is a bad value and indicates that BLKB is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BLKB (1.22) is worse than 62.81% of its industry peers.
The Debt to FCF ratio of BLKB is 6.29, which is on the high side as it means it would take BLKB, 6.29 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BLKB (6.29) is comparable to the rest of the industry.
BLKB has a Debt/Equity ratio of 12.92. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of BLKB (12.92) is worse than 84.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 12.92
Debt/FCF 6.29
Altman-Z 1.22
ROIC/WACC0.93
WACC10.78%
BLKB Yearly LT Debt VS Equity VS FCFBLKB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.84 indicates that BLKB may have some problems paying its short term obligations.
BLKB's Current ratio of 0.84 is on the low side compared to the rest of the industry. BLKB is outperformed by 79.30% of its industry peers.
A Quick Ratio of 0.84 indicates that BLKB may have some problems paying its short term obligations.
BLKB has a Quick ratio of 0.84. This is in the lower half of the industry: BLKB underperforms 79.30% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84
BLKB Yearly Current Assets VS Current LiabilitesBLKB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The earnings per share for BLKB have decreased by -0.70% in the last year.
BLKB shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.74% yearly.
The Revenue has been growing slightly by 0.16% in the past year.
Measured over the past years, BLKB shows a small growth in Revenue. The Revenue has been growing by 5.12% on average per year.
EPS 1Y (TTM)-0.7%
EPS 3Y10.43%
EPS 5Y12.74%
EPS Q2Q%12.04%
Revenue 1Y (TTM)0.16%
Revenue growth 3Y7.59%
Revenue growth 5Y5.12%
Sales Q2Q%-2.06%

3.2 Future

Based on estimates for the next years, BLKB will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.56% on average per year.
The Revenue is expected to grow by 3.05% on average over the next years.
EPS Next Y9.75%
EPS Next 2Y8.63%
EPS Next 3Y7.18%
EPS Next 5Y8.56%
Revenue Next Year-2.71%
Revenue Next 2Y0.68%
Revenue Next 3Y1.83%
Revenue Next 5Y3.05%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BLKB Yearly Revenue VS EstimatesBLKB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
BLKB Yearly EPS VS EstimatesBLKB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.18, BLKB is valued correctly.
Based on the Price/Earnings ratio, BLKB is valued cheaper than 84.56% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.42. BLKB is valued slightly cheaper when compared to this.
BLKB is valuated correctly with a Price/Forward Earnings ratio of 13.37.
85.96% of the companies in the same industry are more expensive than BLKB, based on the Price/Forward Earnings ratio.
BLKB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.18
Fwd PE 13.37
BLKB Price Earnings VS Forward Price EarningsBLKB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLKB indicates a rather cheap valuation: BLKB is cheaper than 83.51% of the companies listed in the same industry.
84.91% of the companies in the same industry are more expensive than BLKB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.96
EV/EBITDA 15.8
BLKB Per share dataBLKB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

BLKB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.56
PEG (5Y)1.19
EPS Next 2Y8.63%
EPS Next 3Y7.18%

0

5. Dividend

5.1 Amount

No dividends for BLKB!.
Industry RankSector Rank
Dividend Yield N/A

BLACKBAUD INC

NASDAQ:BLKB (10/20/2025, 4:20:00 PM)

After market: 64.36 0 (0%)

64.36

+1.32 (+2.09%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-29 2025-10-29/amc
Inst Owners78.27%
Inst Owner Change0.02%
Ins Owners2.01%
Ins Owner Change0.15%
Market Cap3.12B
Analysts50
Price Target78.34 (21.72%)
Short Float %3.06%
Short Ratio3.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.6%
Min EPS beat(2)4.87%
Max EPS beat(2)12.34%
EPS beat(4)2
Avg EPS beat(4)1.98%
Min EPS beat(4)-8.95%
Max EPS beat(4)12.34%
EPS beat(8)6
Avg EPS beat(8)4.02%
EPS beat(12)10
Avg EPS beat(12)4.96%
EPS beat(16)13
Avg EPS beat(16)5.37%
Revenue beat(2)0
Avg Revenue beat(2)-0.64%
Min Revenue beat(2)-1.05%
Max Revenue beat(2)-0.22%
Revenue beat(4)0
Avg Revenue beat(4)-2.01%
Min Revenue beat(4)-4.32%
Max Revenue beat(4)-0.22%
Revenue beat(8)0
Avg Revenue beat(8)-2.3%
Revenue beat(12)0
Avg Revenue beat(12)-2.35%
Revenue beat(16)2
Avg Revenue beat(16)-1.71%
PT rev (1m)0%
PT rev (3m)8.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.52%
EPS NY rev (1m)0%
EPS NY rev (3m)3.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.61%
Valuation
Industry RankSector Rank
PE 15.18
Fwd PE 13.37
P/S 2.74
P/FCF 16.96
P/OCF 12.7
P/B 35.5
P/tB N/A
EV/EBITDA 15.8
EPS(TTM)4.24
EY6.59%
EPS(NY)4.81
Fwd EY7.48%
FCF(TTM)3.79
FCFY5.9%
OCF(TTM)5.07
OCFY7.87%
SpS23.52
BVpS1.81
TBVpS-22.49
PEG (NY)1.56
PEG (5Y)1.19
Profitability
Industry RankSector Rank
ROA -10.63%
ROE -317.65%
ROCE 12.74%
ROIC 10.06%
ROICexc 10.45%
ROICexgc 521.53%
OM 13.95%
PM (TTM) N/A
GM 56.72%
FCFM 16.13%
ROA(3y)-4.27%
ROA(5y)-2.45%
ROE(3y)-68.43%
ROE(5y)-40.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y93.05%
ROICexc growth 5Y27.63%
OM growth 3Y55.49%
OM growth 5Y26.14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.94%
GM growth 5Y0.66%
F-Score6
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 12.92
Debt/FCF 6.29
Debt/EBITDA 4.31
Cap/Depr 59.15%
Cap/Sales 5.42%
Interest Coverage 250
Cash Conversion 93.26%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z 1.22
F-Score6
WACC10.78%
ROIC/WACC0.93
Cap/Depr(3y)61.08%
Cap/Depr(5y)64.81%
Cap/Sales(3y)6.11%
Cap/Sales(5y)6.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.7%
EPS 3Y10.43%
EPS 5Y12.74%
EPS Q2Q%12.04%
EPS Next Y9.75%
EPS Next 2Y8.63%
EPS Next 3Y7.18%
EPS Next 5Y8.56%
Revenue 1Y (TTM)0.16%
Revenue growth 3Y7.59%
Revenue growth 5Y5.12%
Sales Q2Q%-2.06%
Revenue Next Year-2.71%
Revenue Next 2Y0.68%
Revenue Next 3Y1.83%
Revenue Next 5Y3.05%
EBIT growth 1Y41.19%
EBIT growth 3Y67.3%
EBIT growth 5Y32.6%
EBIT Next Year25.45%
EBIT Next 3Y12.63%
EBIT Next 5YN/A
FCF growth 1Y42.47%
FCF growth 3Y12.31%
FCF growth 5Y13.01%
OCF growth 1Y24.74%
OCF growth 3Y11.47%
OCF growth 5Y10.15%